Tinnitus prevalence in Europe: a multi-country cross-sectional population study.
Tinnitus prevalence in Europe: a multi-country cross-sectional population study.
复制标题
DOI:
10.1016/j.lanepe.2021.100250
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Hall DA
中科院分区:
文献类型:
--
作者:
Biswas R;Lugo A;Akeroyd MA;Schlee W;Gallus S;Hall DA
Tinnitus prevalence studies report large variability across countries that might be due to inconsistent research methods. Our study aimed to report a single Pan-European estimate for tinnitus prevalence and investigate the effect of individual and country-level characteristics on prevalence. We explored the relationships of healthcare resource use and hearing difficulty with tinnitus symptoms. Between 2017-2018, a cross-sectional European Tinnitus Survey (ETS) was conducted in 12 European Union nations (Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain), using a standardised set of tinnitus-related questions and response options in country-specific languages. We recruited 11,427 adults aged ≥18 years. Prevalence of any tinnitus was 14·7% (14·0% in men and 15·2% in women), ranging from 8·7% in Ireland to 28·3% in Bulgaria. Severe tinnitus was found in 1·2% participants (1·0% in men and 1·4% in women), ranging from 0·6% in Ireland to 4·2% in Romania. Tinnitus prevalence significantly increased with increasing age and worsening of hearing status. Healthcare resource use for tinnitus increased with increasing tinnitus symptom severity. This is the first multinational report of Pan-European tinnitus prevalence using standardised questions. The overall prevalence estimates refine previous findings, although widespread inter-country heterogeneity was noted. The results indicate that more than 1 in 7 adults in the EU have tinnitus. Extrapolating to the overall population, approximately 65 million adults in EU28 have tinnitus, 26 million have bothersome tinnitus and 4 million have severe tinnitus. National Institute for Health Research, European Union's Horizon 2020, Medical Research Council, and GENDER-Net Co-Plus Fund.
登录
查看更多内容
影响因子:
4.7
作者:
Gallus S;Lugo A;Liu X;Behrakis P;Boffi R;Bosetti C;Carreras G;Chatenoud L;Clancy L;Continente X;Dobson R;Effertz T;Filippidis FT;Fu M;Geshanova G;Gorini G;Keogan S;Ivanov H;Lopez MJ;Lopez-Nicolas A;Precioso J;Przewozniak K;Radu-Loghin C;Ruprecht A;Semple S;Soriano JB;Starchenko P;Trapero-Bertran M;Tigova O;Tzortzi AS;Vardavas C;Vyzikidou VK;Colombo P;Fernandez E;TackSHS Project Investigators
通讯作者:
TackSHS Project Investigators
DOI:
10.1016/s0140-6736(21)00516-x
发表时间:
2021-03-13
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2019 Hearing Loss Collaborators
通讯作者:
GBD 2019 Hearing Loss Collaborators
影响因子:
3.7
作者:
Martinez, Carlos;Wallenhorst, Christopher;Hall, Deborah A.
通讯作者:
Hall, Deborah A.
影响因子:
2.8
作者:
Stockdale D;McFerran D;Brazier P;Pritchard C;Kay T;Dowrick C;Hoare DJ
通讯作者:
Hoare DJ
DOI:
10.1001/jamaoto.2016.1700
发表时间:
2016-10-01
期刊:
JAMA otolaryngology-- head & neck surgery
影响因子:
--
作者:
Bhatt JM;Lin HW;Bhattacharyya N
通讯作者:
Bhattacharyya N